NCT01281072Unknown3 期
Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)
适应症
试验速览
- 阶段
- 3 期
- 主要终点
- c peptide reserve
研究概览
简要总结
Open label study to evaluate long term treatment effect of diapep277.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
入排标准
- 年龄范围
- 20 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patient that completed 901 and 910 study.
排除标准
- •cpeptide<0.2
结局指标
主要结局
c peptide reserve
次要结局
未报告次要终点
研究者
相似试验
终止
3 期
Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®Type 1 DiabetesNCT01898286Andromeda Biotech Ltd.38
已完成
3 期
Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)AsthmaNCT02134028Sanofi2,282
Enrolling By Invitation
3 期
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus ErythematosusSystemic Lupus ErythematosusNCT04976322UCB Biopharma SRL760
进行中（未招募）
3 期
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille SyndromeAlagille SyndromeNCT05035030Albireo, an Ipsen Company62
已完成
3 期
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)AsthmaNCT03620747Sanofi393